{"ORPHApacket":[{"ORPHApacketID":"79328","date":"2019-12-05 18:38:08","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"79328","Name":[{"lang":"en","label":"ALG9-CDG"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79328","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Congenital disorder of glycosylation with epilepsy as a major feature"}],"ORPHA":"371071","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_371071"},{"Name":[{"lang":"en","label":"Disorder of protein N-glycosylation"}],"ORPHA":"309347","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_309347"},{"Name":[{"lang":"en","label":"Congenital disorder of glycosylation with hepatic involvement"}],"ORPHA":"371157","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_371157"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A form of congenital disorders of N-linked glycosylation characterized by progressive microcephaly, hypotonia, developmental delay, drug-resistant infantile epilepsy, and hepatomegaly. Additional features that may be observed include failure to thrive, pericardial effusion, renal cysts, skeletal dysplasia, facial dysmorphism (frontal bossing, hypertelorism, depressed nasal bridge, low-seated ears, large mouth) and hydrops fetalis. The disease is caused by loss-of-function mutations in the gene <i>ALG9<\/i> (11q23)."}],"ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"OMIM","Reference":"608776","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]},{"Source":"OMIM","Reference":"263210","DisorderMappingRelation":[{"id":"21541","Name":[{"lang":"en","label":"BTNT (broader term maps to a narrower term)"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Infancy"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"6","Synonym":[{"lang":"en","label":"CDG syndrome type IL"},{"lang":"en","label":"CDG-IL"},{"lang":"en","label":"CDG1L"},{"lang":"en","label":"Carbohydrate deficient glycoprotein syndrome type IL"},{"lang":"en","label":"Congenital disorder of glycosylation type 1L"},{"lang":"en","label":"Mannosyltransferase 7-9 deficiency"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"ALG9 alpha-1,2-mannosyltransferase"}],"Symbol":"ALG9","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"15672"},{"Source":"OMIM","Reference":"606941"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"410295","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) (loss of function) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"4","HPODisorderAssociation":[{"HPOId":"HP:0001250","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001250","HPOTerm":"Seizures","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001252","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001252","HPOTerm":"Muscular hypotonia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001399","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001399","HPOTerm":"Hepatic failure","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0100543","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0100543","HPOTerm":"Cognitive impairment","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}